Diagnostic testing and treatment choices in primary vitreoretinal lymphoma

Retina

Volumn 31, Issue 3, 2011, Pages 435-440

  Rajagopal, Rithwick ^a,b   Harbour, J William ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BARNES RETINA INSTITUTE   (United States)

Author keywords

CNS lymphoma; external beam radiotherapy; intraocular lymphoma; methotrexate; rituximab; vitreoretinal lymphoma

Indexed keywords

CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYTARABINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN V J; INTERLEUKIN 10; INTERLEUKIN 6; METHOTREXATE; RITUXIMAB; UNCLASSIFIED DRUG; VINCRISTINE;

BLURRED VISION; CANCER CHEMOTHERAPY; CATARACT; CELL INFILTRATION; CLINICAL FEATURE; CORNEA DISEASE; CORNEAL EPITHELIOPATHY; CYTOLOGY; CYTOPATHOLOGY; DEMOGRAPHY; DIAGNOSTIC TEST; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; ENDOPHTHALMITIS; EXTERNAL BEAM RADIOTHERAPY; EYE BIOPSY; FLOW CYTOMETRY; GENE REARRANGEMENT; GENETIC ANALYSIS; HUMAN; IMMUNOCYTOCHEMISTRY; IMMUNOGLOBULIN BLOOD LEVEL; LYMPHOMA; LYMPHOMA CELL; MEDICAL DECISION MAKING; POLYMERASE CHAIN REACTION; PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA; PRIMARY VITREORETINAL LYMPHOMA; PROGNOSIS; RADIATION DOSE; RETINA DETACHMENT; RETINA MACULOPATHY; RETINA RADIATION TRAUMA; RETINA TUMOR; RETINOPATHY; REVIEW; SLIT LAMP; VITREOUS BODY; VITREOUS FLOATERS; VITREOUS HEMORRHAGE;

ANTINEOPLASTIC AGENTS; BIOPSY; DIAGNOSTIC TECHNIQUES, OPHTHALMOLOGICAL; EYE NEOPLASMS; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTRAVITREAL INJECTIONS; LYMPHOMA; POLYMERASE CHAIN REACTION; RADIOTHERAPY; RETINAL NEOPLASMS; VITREOUS BODY;

EID: 79952293028     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/IAE.0b013e31820a6743     Document Type: Review

References (36)

1. Coupland SE, Heimann H, Bechrakis NE. Primary intraocular lymphoma: a review of the clinical, histopathological and molecular biological features. Graefes Arch Clin Exp Ophthalmol 2004;242:901.
2. Cockerham GC, Hidayat AA, Bijwaard KE, Sheng ZM. Re-evaluation of "reactive lymphoid hyperplasia of the uvea": an immunohistochemical and molecular analysis of 10 cases. Ophthalmology 2000;107:151-158.
3. Chan CC, Buggage RR, Nussenblatt RB. Intraocular lymphoma. Curr Opin Ophthalmol 2002;13:411-418. (Pubitemid 35397652)
4. Babu K, Murthy KR, Krishnakumar S. Two successive ocular malignancies in the same eye of a HIV-positive patient: a case report. Ocul Immunol Inflamm 2010;18:101-103.
5. Harbour JW, Char DH. Intraocular lymphoid tumors. In: Chang S, Shields J, Green WR, eds. Retina, Vitreous, Macular: A Comprehensive Text. Philadelphia: Saunders. Pages 1204-1216, 1998.
6. Mathai A, Lall A, Jain R, Pathengay A. Systemic non-Hodgkin's lymphoma masquerading as Vogt-Koyanagi-Harada disease in an HIV-positive patient. Clin Experiment Ophthalmol 2006;34:280-282.
7. Freeman LN, Schachat AP, Knox DL, Michels RG, Green WR. Clinical features, laboratory investigations, and survival in ocular reticulum cell sarcoma. Ophthalmology 1987;94:1631-1639. (Pubitemid 18006894)
8. Berenbom A, Davila RM, Lin HS, Harbour JW. Treatment outcomes for primary intraocular lymphoma: implications for external beam radiotherapy. Eye 2007;21:1198-1201. (Pubitemid 47382147)
9. Hoffman PM, McKelvie P, Hall AJ, Stawell RJ, Santamaria JD. Intraocular lymphoma: a series of 14 patients with clinicopathological features and treatment outcomes. Eye 2003;17:513-521. (Pubitemid 36675767)
10. Davis JL. Diagnosis of intraocular lymphoma. Ocul Immunol Inflamm 2004;12:7-16. (Pubitemid 38406448)
11. Akpek EK, Ahmed I, Hochberg FH, et al. Intraocular-central nervous system lymphoma: clinical features, diagnosis, and outcomes. Ophthalmology 1999;106:1805-1810. (Pubitemid 30194285)
12. Farkas T, Harbour JW, Davila RM. Cytologic diagnosis of intraocular lymphoma in vitreous aspirates. Acta Cytol 2004;48:487-491. (Pubitemid 38955179)
13. Zhai J, Harbour JW, Smith ME, Davila RM. Correlation study of benign cytomorphology and final clinical diagnosis. Acta Cytol 2008;52:196-200. (Pubitemid 351441131)
14. Char DH, Ljung BM, Miller T, Phillips T. Primary intraocular lymphoma (ocular reticulum cell sarcoma) diagnosis and management. Ophthalmology 1988;95:625-630.
15. Zaldivar RA, Martin DF, Holden JT, Grossniklaus HE. Primary intraocular lymphoma: clinical, cytologic, and flow cytometric analysis. Ophthalmology 2004;111:1762-1767. (Pubitemid 39179694)
16. Cassoux N, Giron A, Bodaghi B, et al. IL-10 measurement in aqueous humor for screening patients with suspicion of primary intraocular lymphoma. Invest Ophthalmol Vis Sci 2007;48:3253-3259. (Pubitemid 351261171)
17. Chan CC, Wallace DJ. Intraocular lymphoma: update on diagnosis and management. Cancer Control 2004;11:285-295. (Pubitemid 40310583)
18. Intzedy L, Teoh SC, Hogan A, et al. Cytopathological analysis of vitreous in intraocular lymphoma. Eye 2008;22:289-293. (Pubitemid 351266473)
19. Merle-Beral H, Davi F, Cassoux N, et al. Biological diagnosis of primary intraocular lymphoma. Br J Haematol 2004;124:469-473. (Pubitemid 38230591)
20. Grimm SA, McCannel CA, Omuro AM, et al. Primary CNS lymphoma with intraocular involvement: International PCNSL Collaborative Group Report. Neurology 2008;71:1355-1360.
21. Margolis L, Fraser R, Lichter A, Char DH. The role of radiation therapy in the management of ocular reticulum cell sarcoma. Cancer 1980;45:688-692. (Pubitemid 10174609)
22. Fishburne BC, Wilson DJ, Rosenbaum JT, Neuwelt EA. Intravitreal methotrexate as an adjunctive treatment of intraocular lymphoma. Arch Ophthalmol 1997;115:1152-1156. (Pubitemid 27387951)
23. Kitzmann AS, Pulido JS, Mohney BG, et al. Intraocular use of rituximab. Eye 2007;21:1524-1527.
24. Smith JR, Rosenbaum JT, Wilson DJ, et al. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology 2002;109:1709-1716. (Pubitemid 35012013)
25. Itty S, Pulido JS. Rituximab for intraocular lymphoma. Retina 2009;29:129-132.
26. Ohguro N, Hashida N, Tano Y. Effect of intravitreous rituximab injections in patients with recurrent ocular lesions associated with central nervous system lymphoma. Arch Ophthalmol 2008;126:1002-1003. (Pubitemid 352008390)
27. de Smet MD, Vancs VS, Kohler D, Solomon D, Chan CC. Intravitreal chemotherapy for the treatment of recurrent intraocular lymphoma. Br J Ophthalmol 1999;83:448-451. (Pubitemid 29161187)
28. Itty S, Olson JH, O'Connell DJ, Pulido JS. Treatment of primary intraocular lymphoma (PIOL) has involved systemic, intravitreal or intrathecal chemotherapy and/or radiotherapy. Retina 2009;29:415-416.
29. Hormigo A, Abrey L, Heinemann MH, DeAngelis LM. Ocular presentation of primary central nervous system lymphoma: diagnosis and treatment. Br J Haematol 2004;126:202-208. (Pubitemid 38961938)
30. Isobe K, Ejima Y, Tokumaru S, et al. Treatment of primary intraocular lymphoma with radiation therapy: a multi-institutional survey in Japan. Leuk Lymphoma 2006;47:1800-1805. (Pubitemid 44649763)
31. Abrey LE, DeAngelis LM, Yahalom J. Long-term survival in primary CNS lymphoma. J Clin Oncol 1998;16:859-863. (Pubitemid 28108717)
32. Laack NN, Brown PD. Cognitive sequelae of brain radiation in adults. Semin Oncol 2004;31:702-713. (Pubitemid 39389022)
33. Frenkel S, Hendler K, Siegal T, Shalom E, Pe'er J. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience. Br J Ophthalmol 2008;92:383-388. (Pubitemid 351363536)
34. Sou R, Ohguro N, Maeda T, Saishin Y, Tano Y. Treatment of primary intraocular lymphoma with intravitreal methotrexate. Jpn J Ophthalmol 2008;52:167-174.
35. Rodrigues EB, Farah ME, Maia M, et al. Therapeutic monoclonal antibodies in ophthalmology. Prog Retin Eye Res 2009;28:117-144.
36. Cheng L, Hostetler K, Valiaeva N, et al. Intravitreal crystalline drug delivery for intraocular proliferation diseases. Invest Ophthalmol Vis Sci 2009;51:474-481.